Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fulgent Genetics Inc (FLGT)
NASDAQ:FLGT
Holding FLGT?
Track your performance easily
FLGT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$16.56 - $30.68
Previous Close$17.28
Volume248.78K
Average Volume (3M)168.89K
Market Cap
$519.98M
Enterprise Value$458.80M
Total Cash (Recent Filing)$58.04M
Total Debt (Recent Filing)$412.00K
Price to Earnings (P/E)―
Beta0.81
Next Earnings
Feb 27, 2025EPS Estimate
-$0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.53
Shares Outstanding30,586,811
10 Day Avg. Volume316,132
30 Day Avg. Volume168,891
Standard Deviation0.23
R-Squared0.11
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)0.46
Price to Sales (P/S)1.87
Price to Cash Flow (P/CF)-8.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.65
Enterprise Value/Gross Profit4.39
Enterprise Value/Ebitda-9.93
Forecast
1Y Price Target
$22.00Price Target Upside27.31% Upside
Rating ConsensusHold
Number of Analyst Covering1
Fulgent Genetics News
PremiumCompany Announcements
Fulgent Genetics Reports Q3 2024 Financial Performance
PremiumCompany Announcements
Fulgent Genetics Reports Strong Q3 2024 Results
Ownership Overview
34.49% Insiders
12.00% Mutual Funds
5.83% Other Institutional Investors
29.72% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
FLGT FAQ
What was Fulgent Genetics Inc’s price range in the past 12 months?
Fulgent Genetics Inc lowest stock price was $16.56 and its highest was $30.68 in the past 12 months.
What is Fulgent Genetics Inc’s market cap?
Currently, no data Available
When is Fulgent Genetics Inc’s upcoming earnings report date?
Fulgent Genetics Inc’s upcoming earnings report date is Feb 27, 2025 which is in 98 days.
How were Fulgent Genetics Inc’s earnings last quarter?
Fulgent Genetics Inc released its earnings results on Nov 08, 2024. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of -$0.154 by $0.464.
Is Fulgent Genetics Inc overvalued?
According to Wall Street analysts Fulgent Genetics Inc’s price is currently Undervalued.
Does Fulgent Genetics Inc pay dividends?
Fulgent Genetics Inc does not currently pay dividends.
What is Fulgent Genetics Inc’s EPS estimate?
Fulgent Genetics Inc’s EPS estimate is -$0.12.
How many shares outstanding does Fulgent Genetics Inc have?
Fulgent Genetics Inc has 30,586,811 shares outstanding.
What happened to Fulgent Genetics Inc’s price movement after its last earnings report?
Fulgent Genetics Inc reported an EPS of $0.31 in its last earnings report, beating expectations of -$0.154. Following the earnings report the stock price went down -11.762%.
Which hedge fund is a major shareholder of Fulgent Genetics Inc?
Among the largest hedge funds holding Fulgent Genetics Inc’s share is Caxton Associates LP. It holds Fulgent Genetics Inc’s shares valued at 545K.
---
Fulgent Genetics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$22.00 (27.31% Upside)
$22.00 (27.31% Upside)
Blogger Sentiment
Bullish
FLGT Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth $203.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.3%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.17%
12-Months-Change
Fundamentals
Return on Equity
-13.76%
Trailing 12-Months
Asset Growth
-9.18%
Trailing 12-Months
Company Description
Fulgent Genetics Inc
Fulgent Genetics, Inc. is a technology company, which focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care. Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software, and proprietary laboratory information management systems. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.
---
FLGT Company Deck
---
FLGT Earnings Call
Q3 2024
0:00 / 0:00
---
FLGT Stock 12 Month Forecast
Average Price Target
$22.00
▲(27.31% Upside)
Technical Analysis
---